AzTrials
AzTrials

Airway Complication of AnesthesiaFASTERNCT05899868

Utilization of Airway Stabilizing Rod

A study testing Time to Intubation using FASTER device in people with Airway Complication of Anesthesia, run by Baylor College of Medicine at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The pediatric airway is known to be more challenging than the adult airway when performing endotracheal intubation. When a patient cannot be ventilated and/or intubated, the guidelines for airway management dictate that a laryngeal mask airway (LMA) be used as a rescue device to oxygenate and ventilate the patient. Read more about this study

Who is it for?
Ages 5 to 18 years
Conditions the study is for
Airway Complication of Anesthesia
What is being tested?
Time to Intubation using FASTER device
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
12 Oct 2023to 17 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Ages 5-18 years
  • Requiring intubation
  • Known difficult airway
  • LMA placement possible

Who cannot join

  • Known normal airway
  • Procedure not requiring endotracheal intubation
  • Parental refusal
  • Patient dissent

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Texas Children's Hosppital

    Houston, Texas, 77030

Other trials in United States

About this study

Official title: Utilization of Airway Stabilizing Rod to Assist With LMA Guided Fiberoptic Intubation in Children

The pediatric airway is known to be more challenging than the adult airway when performing endotracheal intubation. When a patient cannot be ventilated and/or intubated, the guidelines for airway management dictate that a laryngeal mask airway (LMA) be used as a rescue device to oxygenate and ventilate the patient. While an excellent device the LMA is seen as temporary and ultimately needs to be replaced by an endotracheal tube (ETT).

Read the detailed description

The objective is to study this device in patients with difficult airway to assess the success rate and time to intubation for placing an endotracheal tube using this device.

Being tested
Time to Intubation using FASTER device

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Time to Intubation using FASTER deviceDevice

    Also called FASTER

    Time from fiberoptic placement onto airway to documentation of end-tidal carbon dioxide waveform through the endotracheal tube.

Study groups in NCT05899868
Study groupRoleWhat they receive
Time to intubation using FASTER deviceOtherTime from fiberoptic placement into airway to documentation of end-tidal carbon dioxide waveform through the endotracheal tube.
Receives: Device: Time to Intubation using FASTER device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overall time in the airway

    Time from fiberoptic placement onto airway to documentation of end-tidal carbon dioxide waveform through the endotracheal tube.

    Measured: 5 minutes

  2. Total time to intubation

    Time from movement of the device to documentation of end-tidal carbon dioxide waveform through the endotracheal tube.

    Measured: 3 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2023
  2. Study start12 Oct 2023
  3. Primary completion17 May 2024
  4. Study completion17 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Model description
Testing of device for success during endotracheal intubation
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05899868
Sponsor's protocol ID
H50120
Acronym
FASTER
Status last verified
Dec 2024
First submitted
16 May 2023
Last updated
5 Dec 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: This pilot data will not be shared

Publications

  • Adler AC, Duong K, Chandrakantan A. Fiberoptic-Assisted Endotracheal Rod for Endotracheal Intubation Through a Supraglottic Airway in Patients with Difficult Intubation: A Clinical Device Study. Anesth Analg. 2025 Apr 1;140(4):986-989. doi: 10.1213/ANE.0000000000007268. Epub 2024 Nov 21. No abstract available.

    PubMed 39774053

Questions about this trial

What is this clinical trial studying?

A study testing Time to Intubation using FASTER device in people with Airway Complication of Anesthesia, run by Baylor College of Medicine at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Overall time in the airway (time frame: 5 minutes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05899868, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in